Vita Life Sciences Ltd (VLS) - Total Assets

Latest as of June 2025: AU$74.64 Million AUD ≈ $52.82 Million USD

Based on the latest financial reports, Vita Life Sciences Ltd (VLS) holds total assets worth AU$74.64 Million AUD (≈ $52.82 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Vita Life Sciences Ltd shareholders equity for net asset value and shareholders' equity analysis.

Vita Life Sciences Ltd - Total Assets Trend (2000–2024)

This chart illustrates how Vita Life Sciences Ltd's total assets have evolved over time, based on quarterly financial data.

Vita Life Sciences Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Vita Life Sciences Ltd's total assets of AU$74.64 Million consist of 81.9% current assets and 18.1% non-current assets.

Asset Category	Amount (AUD)	% of Total Assets
Cash & Equivalents	AU$0.00	39.8%
Accounts Receivable	AU$12.00 Million	16.7%
Inventory	AU$16.60 Million	23.1%
Property, Plant & Equipment	AU$10.33 Million	14.4%
Intangible Assets	AU$50.00K	0.1%
Goodwill	AU$0.00	0.0%

Asset Composition Trend (2000–2024)

This chart illustrates how Vita Life Sciences Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Vita Life Sciences Ltd market cap and net worth.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Vita Life Sciences Ltd's current assets represent 81.9% of total assets in 2024, an increase from 0.0% in 2000.
Cash Position: Cash and equivalents constituted 39.8% of total assets in 2024, up from 7.9% in 2000.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 18.0% in 2000.
Asset Diversification: The largest asset category is inventory at 23.1% of total assets.

Vita Life Sciences Ltd Competitors by Total Assets

Key competitors of Vita Life Sciences Ltd based on total assets are shown below.

Company	Country	Total Assets
Yabao Pharmaceutical Group Co Ltd SHG:600351	China	CN¥3.34 Billion
Jiangsu Hengrui Medicine Co Ltd SHG:600276	China	CN¥68.33 Billion
Sandoz Group AG SW:SDZ	Switzerland	CHF21.61 Billion
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Sweden	Skr67.43 Billion
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Germany	€1.60 Trillion
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	China	CN¥14.22 Billion
Kangmei Pharmaceutical Co Ltd SHG:600518	China	CN¥13.68 Billion
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	China	CN¥19.57 Billion

Vita Life Sciences Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	2.94	2.96	2.17
Quick Ratio	2.21	2.18	1.58
Cash Ratio	1.46	1.46	1.04
Working Capital	AU$39.07 Million	AU$37.24 Million	AU$14.77 Million

Vita Life Sciences Ltd - Advanced Valuation Insights

This section examines the relationship between Vita Life Sciences Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.69
Latest Market Cap to Assets Ratio	1.37
Asset Growth Rate (YoY)	20.2%
Total Assets	AU$71.89 Million
Market Capitalization	$98.55 Million USD

Valuation Analysis

Above Book Valuation: The market values Vita Life Sciences Ltd's assets above their book value (1.37x), reflecting positive investor sentiment about the company's future prospects.

Rapid Asset Growth: Vita Life Sciences Ltd's assets grew by 20.2% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Vita Life Sciences Ltd (2000–2024)

The table below shows the annual total assets of Vita Life Sciences Ltd from 2000 to 2024.

Year	Total Assets	Change
2024-12-31	AU$71.89 Million ≈ $50.87 Million	+20.21%
2023-12-31	AU$59.81 Million ≈ $42.32 Million	+15.46%
2022-12-31	AU$51.80 Million ≈ $36.65 Million	+14.42%
2021-12-31	AU$45.27 Million ≈ $32.03 Million	+15.77%
2020-12-31	AU$39.10 Million ≈ $27.67 Million	+7.10%
2019-12-31	AU$36.51 Million ≈ $25.84 Million	+2.22%
2018-12-31	AU$35.72 Million ≈ $25.27 Million	+8.39%
2017-12-31	AU$32.95 Million ≈ $23.32 Million	+1.84%
2016-12-31	AU$32.36 Million ≈ $22.90 Million	-0.09%
2015-12-31	AU$32.39 Million ≈ $22.92 Million	+6.99%
2014-12-31	AU$30.27 Million ≈ $21.42 Million	+37.54%
2013-12-31	AU$22.01 Million ≈ $15.57 Million	+30.90%
2012-12-31	AU$16.81 Million ≈ $11.90 Million	+25.95%
2011-12-31	AU$13.35 Million ≈ $9.45 Million	-8.01%
2010-12-31	AU$14.51 Million ≈ $10.27 Million	+64.72%
2009-12-31	AU$8.81 Million ≈ $6.23 Million	+1.96%
2008-12-31	AU$8.64 Million ≈ $6.11 Million	+28.41%
2007-12-31	AU$6.73 Million ≈ $4.76 Million	-47.06%
2006-12-31	AU$12.71 Million ≈ $8.99 Million	-20.30%
2005-12-31	AU$15.95 Million ≈ $11.28 Million	-16.11%
2004-12-31	AU$19.01 Million ≈ $13.45 Million	-2.99%
2003-12-31	AU$19.60 Million ≈ $13.87 Million	-42.61%
2002-12-31	AU$34.15 Million ≈ $24.16 Million	-48.30%
2001-12-31	AU$66.05 Million ≈ $46.74 Million	+34.94%
2000-12-31	AU$48.95 Million ≈ $34.63 Million	--

About Vita Life Sciences Ltd

AU:VLS Australia Drug Manufacturers - Specialty & Generic

Market Cap

$98.55 Million

AU$139.28 Million AUD

Market Cap Rank

#19233 Global

#631 in Australia

Share Price

AU$2.55

Change (1 day)

+0.79%

52-Week Range

AU$1.73 - AU$2.83

All Time High

AU$2.83